Development of intervention-related quality indicators for renal clinical pharmacists using a modified Delphi approach.

Objective: To develop a list of renal Quality Indicator Drug therapy problems (QI-DTPs) that serve to advance renal pharmacy practice to improve patient care.

Methods: Eighteen (18) renal, clinical pharmacists participated in an internet-based three-round modified Delphi survey. Each of the three rounds took approximately 2 weeks to complete.

Efficacy and safety data of subsequent entry biologics pertinent to nephrology practice: a systematic review.

Background: Subsequent entry biologics (SEBs) may soon be a reality in Canadian nephrology practice. Understanding the worldwide experience with these agents will be valuable to Canadian clinicians.

Objectives: To compare the efficacy and safety data between SEBs used in nephrology practice and their reference biologic.

Potential impact of subsequent entry biologics in nephrology practice in Canada.

Purpose Of Review: Subsequent entry biologics may soon be a reality in Canadian nephrology practice. Along with opportunities to reduce health care costs, these agents pose unique challenges that must be met for successful implementation. Understanding the experiences around the globe in both regulatory affairs and implementation will be a valuable guide for Canadian clinicians.